1-157580329-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031282.3(FCRL4):c.1269C>G(p.Asp423Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D423G) has been classified as Uncertain significance.
Frequency
Consequence
NM_031282.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCRL4 | ENST00000271532.2 | c.1269C>G | p.Asp423Glu | missense_variant | Exon 8 of 12 | 1 | NM_031282.3 | ENSP00000271532.1 | ||
FCRL4 | ENST00000448509.6 | n.1010C>G | non_coding_transcript_exon_variant | Exon 6 of 9 | 2 | |||||
FCRL4 | ENST00000479869.1 | n.209C>G | non_coding_transcript_exon_variant | Exon 1 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461802Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727212
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1269C>G (p.D423E) alteration is located in exon 8 (coding exon 8) of the FCRL4 gene. This alteration results from a C to G substitution at nucleotide position 1269, causing the aspartic acid (D) at amino acid position 423 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at